Early changes in prostaglandins precede bone formation in a rabbit model of heterotopic ossification

Bone

Volumn 38, Issue 3, 2006, Pages 322-332

  Bartlett, Craig S ^a   Rapuano, Bruce E ^b   Lorich, Dean G ^c   Wu, Timothy ^d   Anderson, Richard C ^e   Tomin, Emre ^b   Hsu, John F ^f   Lane, Joseph M ^g   Helfet, David L ^g  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c JACOBI MEDICAL CENTER   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Heterotopic ossification; Myositis ossificans; Prostaglandins

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; ADENOSINE RECEPTOR BLOCKING AGENT; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; RP CYCLIC AMP; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE RADIOGRAPHY; CONTROLLED STUDY; EXERCISE; HETEROTOPIC OSSIFICATION; IN VIVO STUDY; KNEE FUNCTION; MUSCLE LEVEL; NONHUMAN; RABBIT; VASTUS MEDIALIS MUSCLE;

ANIMALS; CYCLIC AMP; DISEASE MODELS, ANIMAL; FEMUR; FOLLOW-UP STUDIES; HINDLIMB; IMMOBILIZATION; MUSCLE, SKELETAL; OSSIFICATION, HETEROTOPIC; OSTEOGENESIS; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS; RABBITS; THIONUCLEOTIDES; TIME FACTORS; XANTHONES;

EID: 32844461217     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.08.016     Document Type: Article

References (88)

1. A.J.G. Nollen, and T.J.J.H. Slooff Para-articular ossifications after total hip replacement Acta Orthop. Scand. 44 1973 230 241
2. J.R. Sawyer, M.A. Myers, R.N. Rosier, and J.E. Puzas Heterotopic ossification: clinical and cellular aspects Calcif. Tissue Int. 49 1991 208 215
3. J.E. Puzas, J.S. Brand, and C.M. Evarts The stimulus for bone formation R.A. Brand The Hip 1987 C.V. Mosby St. Louis 25 38
4. A.Y. Friedenstein Induction of bone tissue by transitional epithelium Clin. Orthop. 59 1968 21 37
5. P. Kjaersgaard-Andersen, and M.A. Ritter Short-term treatment with nonsteroidal antiinflammatory medications to prevent heterotopic bone formation after total hip arthroplasty Clin. Orthop. 279 1992 157 162
6. A.F. Brooker, J.W. Bowerman, R.A. Robinson, and L.H. Riley Jr. Ectopic ossification following total hip replacement: incidence and a method of classification J. Bone Joint Surg. 55-A 1973 1629 1632
7. P. Gebuhr, M. Soelberg, T. Orsnes, and H. Wilbeck Naproxen prevention of heterotopic ossification after hip arthroplasty: a prospective control study of 55 patients Acta Orthop. Scand. 62 1991 226 229
8. L. Ahrengart, G. Blomgren, and H. Tornkvist Short-term ibuprofen to prevent ossification after hip arthoplasty Acta Orthop. Scand. 65 1994 139 141
9. J. Charnley The long term results of low-friction arthroplasty of the hip performed as primary intervention J. Bone Joint Surg. Br 54 1972 61 76
10. A. Chantraine, and P. Minaire Para-osteo-arthropathies: a new theory and mode of treatment Scand J Rehabil Med 13 1 1981 31 37
11. D.E. Garland Fractures and dislocations about the hip in head-injured patients Clin. Orthop. 186 1984 154 158
12. M.A. Mital, J.E. Garber, and J.T. Stinson Ectopic bone formation in children and adolescents with head injuries and its management J. Pediatr. Orthop. 7 1987 83 90
13. S.L. Peterson, M.M. Mani, C.M. Crawforsd, J.R. Neff, and J.M. Hiebert Postburn heterotopic ossification: insights for management decision making J. Trauma 29 1989 365 369
14. E.B. Evans Heterotopic bone formation in thermal burns Clin. Orthop. 263 1991 94 101
15. B.R. Moed, and D.E. Karges Prophylactic indomethacin for the prevention of heterotopic ossification after acetabular fracture surgery in high risk patients J. Orthop. Trauma 8 1994 34 39
16. B.R. Moed The effect of indomethacin on heterotopic ossification following acetabular surgery [Abstract] J. Orthop. Trauma 3 1989 172
17. J.E. Alonso, R. Davila, and E. Bradley Extended iliofemoral versus triradiate approaches in management of associated acetabular fractures Clin. Orthop. 305 1994 81 87
18. M.K. Bosse, A. Poka, C.M. Reinert, F. Ellwanger, R. Slawson, and E.R. McDevitt Heterotopic ossification as a complication of acetabular fracture: prophylaxis with low-dose irradiation J. Bone Joint Surg. 70 1988 1231 1237
19. E. Letournel, and R. Judet R.A. Elson Fractures of the Acetabulum 2nd ed 1993 Springer-Verlag New York vol.
20. F.A. Kaempffe, L. Bone, and J.R. Border Open reduction and internal fixation of acetabular fractures: heterotopic ossification and other complications of treatment J. Orthop. Trauma 5 1991 439 445
21. A.C. McLaren Prophylaxis with indomethacin for heterotopic bone. After open reduction of fractures of the acetabulum J. Bone Joint Surg. Am. 72 1990 245 247
22. L. Ahrengart, and U. Lingren Prevention of ectopic bone formation by local application of ethane-1-hydroxy-1, 1-diphosphonate (EHDP): an experimental study in rabbits J. Orthop. Res. 4 1986 18 26
23. D.E. Garland A clinical perspective on common forms of acquired heterotopic ossification Clin. Orthop. 263 1991 13 29
24. S.A. Schmidt, P. Kjaersgaard-Andersen, N.W. Pederson, S.S. Kristensen, P. Pederson, and J.B. Nielsen The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement J. Bone Joint Surg. Am. 77 1988 834 838
25. D.E. Foster, and J.R. Hunter The direct lateral approach to the hip for arthroplasty. Advantages and complications Orthopedics 10 1987 274
26. B.R. Moed, R.B. Resnick, A.J. Fakhouri, B. Nallamothu, and R.A. Wagner Effect of two nonsteroidal antiinflammatory drugs on heterotopic bone formation in a rabbit model J. Arthroplasty 9 1994 81 87
27. H. Tomkvist, C.H. Bauer, and O.S. Nilsson Influence of indomethacin on experimental bone metabolism in rats Clin. Orthop. 193 1985 264 270
28. J. Ro, E. Sudman, and P.F. Marton Effect of indomethacin on fracture healing in rats Acta Orthop. Scand. 47 1976 588 599
29. M.W. Elves, I. Bayley, and P.J. Roylance The effect of indomethacin upon experimental fractures in the rat Acta Orthop. Scand. 53 1982 35 41
30. H.L. Allen, A. Wase, and W.T. Bear Indomethacin and aspirin: effect of nonsteroidal antiinflammatory agents on the rate of fracture repair in the rat Acta Orthop. Scand. 51 1980 595 600
31. E. Sudmann, and G. Bang Indomethacin-induced inhibition of haversian remodeling in rabbits Acta Orthop. Scand. 50 1979 621 627
32. R.D. Altman, L.L. Latta, R. Keer, K. Renfree, F.J. Hornicek, and K. Banovac Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study J. Orthop. Trauma 9 1995 392 400
33. J.C. Keller, T.M. Trancik, F.A. Young, and E. St Mary The effects of indomethacin on bone growth J. Orthop. Res. 7 1989 28 34
34. T. Trancik, W. Mills, and N. Vinson The effect of indomethacin, aspirin, and ibuprofen on bone ingrowth into a porous-coated implant Clin. Orthop. 249 1989 113 121
35. W.J. Daum, M.T. Scarborough, W. Gordon, and T. Uchida Heterotopic ossification and other perioperative complications of acetabular fractures J. Orthop. Trauma 6 1992 427 432
36. J.P. Cella, E.A. Salvati, and T.P. Sculco Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects J. Arthroplasty 3 1988 229 234
37. J.H. Kim, F.C. Chu, H.Q. Woodard, M.R. Melamed, A. Huvos, and J. Cantin Radiation-induced soft tissue and bone sarcoma Radiology 129 1978 501 508
38. L.W. Brady Radiation-induced sarcomas of bone Skeletal Radiol. 4 1979 72 78
39. J.E. Michelsson, G. Granroth, and L.C. Andersson Myositis ossificans following forcible manipulation of the leg J. Bone Joint Surg. Am. 1980 811 815
40. H.J. Aho, H. Aro, S. Juntunen, L. Strengell, and J. Michelsson Bone formation in experimental myositis ossificans: light and electron microscopic study APMIS 96 1988 933 940
41. Ahrengart L. Trauma-induced heterotopic bone formation. Thesis, Karolinska Institute, Stockholm, Sweden, 1989.
42. S. Weintroub, L.M. Wahl, N. Feuerstein, C.C. Winter, and A.H. Reddi Changes in tissue concentration of prostaglandins during endochondral bone differentiation Biochem. Biophys. Res. Commun. 117 1983 746 750
43. J. Michelsson, and W. Rauschning Pathogenesis of experimental heterotopic bone formation following temporary forcible exercising of immobilized limbs Clin. Orthop. 176 1983 265 272
44. T. Kobayashi, and S. Narumiya Function of prostanoid receptors: studies on knockout mice Prostaglandins Other Lipid. Mediat. 68-69 2002 557 573
45. K. Yokota, M. Kusaka, T. Oshima, S. Yamamoto, N. Kurihara, and T. Yoshino Stimulation of prostaglandin E2 synthesis in cloned osteoblastic cells of mouse (MC3T3-E1) by epidermal growth factor J. Biol. Chem. 261 1986 15410 15415
46. R.W. Norrdin, W.S.S Jee, and W.B. High The role of prostaglandins in bone in vivo Prostaglandins Leukot. Essent. Fatty Acids 41 1990 139
47. W.S.S. Jee, Y.F. Ma, and M. Li Sex steroids and prostaglandins in bone metabolism Ernst Schering Research Foundation Workshop 9, Sex Steroids and Bone 1994 Springer-Verlag 119
48. S.C. Miller, and S.C. Marks Jr. Local stimulation of new bone formation by prostaglandin E1: quantitative histomorphometry and comparison of delivery by minipumps and controlled release pellets Bone 14 1993 143
49. R.S. Yang, T.K. Liu, and S.Y. Lin-Shiau Increased bone growth by local prostaglandin E2 in rats Calcif. Tissue Int. 52 1993 57
50. O. Kozawa, H. Tokuda, M. Miwa, J. Kotoyori, and Y. Oiso Cross-talk regulation between cyclic AMP production and phosphoinositide hydrolysis by prostaglandin E2 in osteoblast-like cells Exp. Cell Res. 198 1992 130
51. R.W. Farndale, J.R. Sandy, S.J. Atkinson, S.R. Pennington, S. Meghji, and M.C. Meikle Parathyroid hormone and prostaglandin E2 stimulate both inositol phosphates and cyclic AMP accumulation in mouse osteoblast cultures Biochem. J. 252 1988 263
52. Y. Hakeda, T. Hotta, N. Kurihara, E. Ikeda, N. Maeda, and Y. Yagyu Prostaglandin E1 and F2alpha stimulate differentiation and proliferation, respectively, of clonal osteoblastic MC3T3-E1 cells by different second messengers in vitro Endocrinology 121 1987 1966 1974
53. M.A. Gallant, R. Samadfam, J.A. Hackett, J. Antoniou, J.L. Parent, and A.J. de Brum-Fernandes Production of prostaglandin D2 by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors J. Bone Miner. Res. 20 2005 672 681
54. M.P. Akhter, D.M. Cullen, G. Gong, and R.R. Recker Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice Bone 29 2001 121 125
55. C.A. Clark, E.M. Schwarz, X. Zhang, N.M. Ziran, H. Drissi, and R.J. O'keefe Differential regulation of EP receptor isoforms during chondrogenesis and chondrocyte maturation Biochem. Biophys. Res. Commun. 328 2005 764 776
56. G.A. Balint, H. Hulesch, and R. Ceserani The effect of different prostaglandins on gastric mucosal intracellular second messengers in the rat Acta Physiol. Hung. 79 1992 233 239
57. K. Toriyama, I. Morita, and S. Murota The existence of distinct classes of prostaglandin E2 receptors mediating adenylate cyclase and phospholipase C pathways in osteoblastic clone MC3T3-E1 Prostaglandins Leukot. Essent. Fatty Acids 46 1992 15 20
58. J.E. Tateson, S. Moncada, and J.R. Vane Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets Prostaglandins 13 1977 389 397
59. R.R. Gorman, S. Bunting, and O.V. Miller Modulation of human platelet adenylate cyclase by prostacyclin Prostaglandins 13 1977 377 388
60. J.C. Clohisy, T.J. Connolly, K.D. Bergman, C.O. Quinn, and N.C. Partridge Prostanoid-induced expression of matrix metalloproteinase-1 messenger ribonucleic acid in rat osteosarcoma cells Endocrinology 135 1994 1447 1454
61. S. Saito, K. Yamasdaki, S. Yamada, A. Matsumoto, T. Akatsu, and N. Takahashi A stable analogue of thromboxane A2, 9, 11-epithio-11,12- methanothromboxane A2, stimulates bone resorption in vitro and osteoclast-like cell formation in mouse marrow culture Bone Miner. 12 1991 15 23
62. R. Vezza, G.G. Nenci, and P. Gresele Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylcyclase up-regulation J. Pharmacol. Exp. Ther. 275 1995 1497 1505
63. F. Ushikubi, Y. Sugimoto, A. Ichikawa, and S. Narumiya Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors Jpn. J. Pharmacol. 83 2000 279 285
64. V.M. Paralkar, F. Borovecki, H.Z. Ke, K.O. Cameron, B. Lefker, and W.A. Grasser An EP2 receptor-selective E2 agonist induces bone healing Proc. Natl. Acad. Sci. 100 2003 6736 6740
65. M. Li, H.Z. Ke, H. Qi, D.R. Healy, Y. Li, and D.T. Crawford A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing J Bone Miner. Res. 18 2003 2033 2042
66. M. Machwate, S. Harada, C.T. Leu, G. Seedor, M. Labelle, and M. Gallant Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2) Mol. Pharmacol. 64 2003 192
67. R. Sasaoka, H. Terai, H. Toyoda, Y. Imai, R. Sugama, and K. Takaoka A prostanoid receptor EP4 agonist enhances ectopic bone formation by recombinant human bone morphogenetic protein-2 Biochem. Biophys. Res. Commun. 318 2004 704 709
68. M. Li, D.R. Healy, Y. Li, H.A. Simmons, D.T. Crawford, and H.Z. Ke Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice Bone 2005 [April 30]
69. H. Hagino, M. Kuraoka, Y. Kameyama, T. Okano, and R. Teshima Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading Bone 36 2005 444 453
70. K. Yoshida, H. Oida, T. Kobayashi, T. Maruyama, M. Tanaka, and T. Katayama Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation Proc. Natl. Acad. Sci. 99 2002 4580 4585
71. L.G. Raisz, C.B. Alander, P.M. Fall, and H.A. Simmons Effects of prostaglandin F2 on bone formation and resorption in cultured neonatal mouse calvariae: role of prostaglandin E2 production Endocrinology 126 1990 1076 1079
72. D.A. Collins, and T.J. Chambers Effect of prostaglandins E1, E2, and F2alpha on osteoclast formation in mouse bone marrow cultures J. Bone Miner. Res. 6 1991 157 164
73. A.M. Fianagan, and T.J. Chambers Stimulation of bone nodule formation in vitro by prostaglandins E1 and E2 Endocrinology 130 1992 443 448
74. R.A. Coleman, I. Kennedy, and R.L.G. Sheldrick New evidence with selective agonists and antagonists for the subclassification of PGE2-sensitive (EP) receptors Adv. Prostaglandin Thromboxane Leukot. Res. 17 1987 467 470
75. R.J. Keery, and P. Lumley AH 6809, a prostaglandin DP receptor blocking drug on human platelets Br. J. Pharmacol. 94 1988 745 754
76. D.F. Woodward, D.J. Pepperl, T.H. Burkey, and J.W. Regan 6-Isopropoxy-9-oxoxanthine-2-carboxylic acid (AH 6809), a human EP2-receptor antagonist Biochem. Pharmacol. 50 1995 1731 1733
77. H.-G. Scholubbers, P.H. Van Knippenberg, J. Baraniak, W.J. Stec, M. Morr, and B. Jastorff Investigations on stimulation of lac transcription in vivo in Escherichia coli by cAMP analogs. Biological activities and structure-activity correlations Eur. J. Biochem. 138 1984 101 109
78. J. Michelsson, M. Pettila, T. Valtakari, I. Leivo, and H.J. Aho Isolation of bone from muscles prevents the development of experimental callus-like heterotopic bone Clin. Orthop. 302 1994 266 272
79. J.E. Michelsson, S. Juntunen, T. Valtakari, and J. Mikkola Methylprednisolone has a preventive effect on heterotopic bone formation and on knee thickening and stiffening following manipulation of immobilized rabbit legs Clin. Exp. Rheumatol. 12 1994 409 413
80. H. Brown, H.P. Ehrlich, and P.M. Newberne Para osteo arthropathy-ectopic ossification of healing tendon about the rodent ankle joint: histologic and type V collagen changes Proc. Soc. Exp. Biol. Med. 183 1986 214 220
81. W.S. Powell Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica Prostaglandins 20 1980 947 957
82. L.G. Raisz, C.C. Pilbeam, and P.M. Fall Prostaglandins: mechanisms of action and regulation of production in bone Osteoporosis Int. 1993 136 140
83. Y. Hakeda, T. Hotta, N. Kurihara, E. Ikeda, N. Maeda, and Y. Yagyu Prostaglandin E1 and F2alpha stimulate differentiation and proliferation, respectively, of clonal osteoblastic MC3T3-E1 cells by different second messengers in vitro Endocrinology 121 1987 1966 1974
84. J. Blebea, R.A. Cambria, D. DeFouw, R.N. Feinberg, R.W. Hobson II, and W.N. Duran Iloprost attenuates the increased permeability in skeletal muscle after ischemia and reperfusion J. Vasc. Surg. 12 1990 657 665
85. I.A. Thomson, S. Egginton, M.H. Simms, and O. Hudlicka Effect of muscle ischaemia and iloprost during femorodistal reconstruction on capillary endothelial swelling Int. J. Microcirc. 16 1996 284 290
86. M. Muller, R. Schmid, M. Nieszpaur-Los, A. Fassolt, P. Lonroth, and P. Fasching Key metabolite kinetics in human skeletal muscle during ischaemia and reperfusion: measurement by microdialysis Eur. J. Clin. Invest. 25 1995 601 607
87. C. Miyaura, M. Inada, T. Suzawa, Y. Sugimoto, F. Ushikubi, and A. Ichikawa Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice J. Biol. Chem. 275 2000 19819 19823
88. M. Tanaka, A. Sakai, S. Uchida, T. Nagashima, T. Katayama, and K. Yamaguchi Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats Bone 34 2004 940 948